Literature DB >> 3335575

Dedifferentiated chondrosarcoma.

R Capanna1, F Bertoni, G Bettelli, P Picci, P Bacchini, D Present, A Giunti, M Campanacci.   

Abstract

The cases of forty-six patients who had dedifferentiated chondrosarcoma were reviewed. Two groups were identified: one in which a low-grade malignant chondrosarcoma was the precursor lesion and one in which a moderate to high-grade malignant chondrosarcoma was the precursor lesion. The radiographic features of these lesions ranged from that of a cartilaginous lesion that appeared to be benign to that of a destructive osteolytic tumor in which the cartilaginous component was overshadowed by the dedifferentiated component. Only three of the forty-six patients survived for more than two years. Resection alone, even when it was wide or radical, was not successful in controlling this lethal sarcoma.

Entities:  

Mesh:

Year:  1988        PMID: 3335575

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  22 in total

1.  Morphological typing of chondrosarcoma: a study of 94 cases.

Authors:  H Welkerling; T Dreyer; G Delling
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.

Authors:  Rieko Oyama; Fusako Kito; Mami Takahashi; Marimu Sakumoto; Kumiko Shiozawa; Zhiwei Qiao; Rei Noguchi; Takashi Kubo; Shunichi Toki; Fumihiko Nakatani; Akihiko Yoshida; Akira Kawai; Tadashi Kondo
Journal:  Hum Cell       Date:  2019-02-08       Impact factor: 4.174

3.  Dedifferentiated chondrosarcoma of humerus with giant cell tumor-like features.

Authors:  T Ishida; H D Dorfman; E T Habermann
Journal:  Skeletal Radiol       Date:  1995-01       Impact factor: 2.199

4.  Dedifferentiated chondrosarcoma--a fatal disease.

Authors:  J Bruns; W Fiedler; M Werner; G Delling
Journal:  J Cancer Res Clin Oncol       Date:  2005-03-23       Impact factor: 4.553

5.  A reproducible and simple grading system for classical chondrosarcomas. Analysis of 35 chondrosarcomas and 16 enchondromas with emphasis on recurrence rate and radiological and clinical data.

Authors:  Heike Welkerling; Susanne Kratz; Volker Ewerbeck; Günter Delling
Journal:  Virchows Arch       Date:  2003-09-25       Impact factor: 4.064

6.  Maffucci's syndrome combined with dedifferentiated chondrosarcoma.

Authors:  H Tsuchiya; K Tomita; H Yasutake; Y Takagi; Y Ueda; M Kadoya
Journal:  Arch Orthop Trauma Surg       Date:  1991       Impact factor: 3.067

7.  Does ifosfamide therapy improve survival of patients with dedifferentiated chondrosarcoma?

Authors:  Satoshi Kawaguchi; Tao Sun; Patrick P Lin; Michael Deavers; Nusrat Harun; Valerae O Lewis
Journal:  Clin Orthop Relat Res       Date:  2013-11-07       Impact factor: 4.176

8.  HDAC4 represses vascular endothelial growth factor expression in chondrosarcoma by modulating RUNX2 activity.

Authors:  Xiaojuan Sun; Lei Wei; Qian Chen; Richard M Terek
Journal:  J Biol Chem       Date:  2009-06-09       Impact factor: 5.157

9.  Dedifferentiated chondrosarcoma of the appendicular skeleton: MRI-pathological correlation.

Authors:  Fergus MacSweeney; Alan Darby; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2003-10-30       Impact factor: 2.199

10.  Dedifferentiated chondrosarcoma.

Authors:  M Mercuri; P Picci; L Campanacci; E Rulli
Journal:  Skeletal Radiol       Date:  1995-08       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.